# Phase 2A & 2B Implementation - COMPLETE ✅

## 🎉 Status: VARIANT AUGMENTATION READY

Phase 2A (basic variant augmentation) and Phase 2B (differential prediction) are now fully integrated!

## ✅ What's Implemented

### Phase 2A: Basic Variant Augmentation (33/33/33 Strategy)

**Three augmentation modes:**
1. **Reference (33%)**: No variant applied
   - Sequence: Reference
   - Labels: Reference
   - Teaching: Normal patterns

2. **Benign Variant (33%)**: Variant applied to sequence, labels unchanged
   - Sequence: Altered (variant applied)
   - Labels: Reference (SAME!)
   - Teaching: "This sequence change is OK"

3. **Pathogenic Variant (33%)**: Variant applied, labels modified
   - Sequence: Altered (variant applied)
   - Labels: Modified based on variant effect
   - Teaching: "This sequence change breaks things"

**Key Methods Added:**
- `_apply_variant_to_sequence()` - Apply variant to DNA sequence
- `_get_augmentation_mode()` - Decide 33/33/33 mode
- `_recompute_labels_for_variant()` - Modify labels for pathogenic variants

### Phase 2B: Differential Prediction

**Variant Effect Prediction:**
- Uses SpliceVar `splice_effect_score` (0-1) as ground truth
- Predicts variant effect on splicing
- Modifies splice site labels for strong effects (score > 0.5)

**Label Recomputation Logic:**
```python
if variant['is_benign']:
    # Benign: sequence changes, function doesn't
    labels_alt = labels_ref  # SAME
    
elif variant['is_pathogenic']:
    # Pathogenic: sequence AND function change
    if variant['splice_effect_score'] > 0.5:
        # Flip splice site labels at variant position
        labels_alt['donor'][pos] = 1 - labels_ref['donor'][pos]
        labels_alt['acceptor'][pos] = 1 - labels_ref['acceptor'][pos]
```

**New Output:**
- `variant_effect`: Predicted splice effect score (0-1)
- `augmentation_mode`: 'reference', 'benign', or 'pathogenic'

## 📊 Updated Loss Computation

### All 12 Loss Terms (Phase 1 + 2):

**Phase 1 (9 losses):**
1. `loss/donor` - Splice donor sites
2. `loss/acceptor` - Splice acceptor sites
3. `loss/tss` - Transcription start sites
4. `loss/polya` - Polyadenylation sites
5. `loss/protein` - Protein sequence (21-way)
6. `loss/cds_start` - CDS start boundary
7. `loss/cds_end` - CDS end boundary
8. `loss/nmd` - NMD prediction
9. `loss/expression` - Log TPM prediction

**Phase 2 (3 losses):**
10. `loss/splice_effect` - Splice effect consistency
11. `loss/variant_effect` - Variant effect prediction (NEW)
12. `loss/total` - Weighted sum of all losses

### Loss Weights:
```python
# Phase 1 weights
w_splice_donor = 1.0
w_splice_acceptor = 1.0
w_tss = 0.5
w_polya = 0.5
w_protein = 2.0
w_cds_start = 0.5
w_cds_end = 0.5
w_nmd = 1.0
w_expression = 1.0

# Phase 2 weight
w_variant_effect = 0.5
```

## 🔄 Updated __getitem__ Flow

```
1. Load reference data from parquet
   ↓
2. Decide augmentation mode (33/33/33)
   ├─ 33%: reference
   ├─ 33%: benign variant
   └─ 33%: pathogenic variant
   ↓
3. Parse variants from row
   ↓
4. Select variant based on mode
   ↓
5. Apply variant to sequence (if selected)
   ↓
6. Tokenize sequence
   ↓
7. Create Phase 1 labels (protein, CDS, NMD, expression)
   ↓
8. Recompute labels for variant (Phase 2B)
   ├─ Benign: keep labels same
   └─ Pathogenic: modify splice labels if strong effect
   ↓
9. Return augmented example with:
   - input_ids (tokenized sequence)
   - attention_mask
   - labels (all 10 label types)
   - augmentation_mode (for logging)
   - variant_effect (SpliceVar score)
```

## 🎯 Training with Phase 2

### Expected Behavior

**Training batch composition:**
```
Batch of 32 examples:
├─ ~11 reference examples (33%)
├─ ~11 benign variant examples (33%)
└─ ~10 pathogenic variant examples (33%)
```

**Loss logging:**
```
train/loss: 0.45
train/loss/donor: 0.05
train/loss/acceptor: 0.04
train/loss/tss: 0.02
train/loss/polya: 0.02
train/loss/protein: 0.15
train/loss/cds_start: 0.05
train/loss/cds_end: 0.05
train/loss/nmd: 0.02
train/loss/expression: 0.05
train/loss/splice_effect: 0.02
train/loss/variant_effect: 0.01  # NEW Phase 2B
```

## 🚀 Quick Start

```bash
# Train with Phase 1 + 2 augmentation
poetry run python training/train.py

# Test on 1 batch
poetry run python training/train.py \
    --limit_train_batches 1 \
    --limit_val_batches 1 \
    --max_epochs 1
```

## 📁 Code Changes

**Modified `training/train.py`:**

1. **Added Phase 2A methods** (lines 662-744):
   - `_apply_variant_to_sequence()` - Apply variant to DNA
   - `_recompute_labels_for_variant()` - Modify labels for variants
   - `_get_augmentation_mode()` - 33/33/33 decision

2. **Updated `__getitem__`** (lines 746-883):
   - Phase 2A: Variant selection and application
   - Phase 2B: Label recomputation
   - Returns augmentation_mode and variant_effect

3. **Updated loss computation** (lines 1284-1352):
   - Added Phase 1 losses (protein, CDS, NMD, expression)
   - Added Phase 2B variant effect loss
   - 12 total loss terms

## 🎓 What the Model Learns

### Phase 1 (Reference Data Only)
- DNA → RNA: TSS, PolyA, Expression
- RNA → Splicing: Donor/Acceptor sites
- RNA → Protein: Protein sequence, CDS boundaries
- Quality: NMD prediction

### Phase 2A (With Benign Variants)
- Benign variants don't change function
- Model learns robustness to sequence variation
- Prevents overfitting to reference sequence

### Phase 2B (With Pathogenic Variants)
- Pathogenic variants change function
- SpliceVar scores guide learning
- Model learns variant effects on splicing
- Differential prediction: ref → alt changes

## 💡 Key Design Decisions

1. **33/33/33 Strategy**: Balanced training on reference, benign, pathogenic
2. **Benign = Unchanged Labels**: Teaches model that not all variants are harmful
3. **Pathogenic = Modified Labels**: Teaches model which changes matter
4. **SpliceVar Integration**: Uses real variant effect predictions as ground truth
5. **Deterministic in Val/Test**: No augmentation during validation/testing

## ✨ Summary

**Phase 2 is COMPLETE!**

Both Phase 2A (basic augmentation) and Phase 2B (differential prediction) are fully integrated:
- ✅ 33/33/33 augmentation strategy
- ✅ Benign variant handling (sequence changes, labels don't)
- ✅ Pathogenic variant handling (sequence AND labels change)
- ✅ SpliceVar integration for variant effect prediction
- ✅ 12 loss terms (9 Phase 1 + 3 Phase 2)
- ✅ Ready to train with variants

**Next Steps:**
1. Train Phase 1+2 model
2. Evaluate variant effect predictions
3. Phase 3: Advanced variant effects (protein changes, NMD)

**Start training:**
```bash
poetry run python training/train.py
```

The model will now learn from:
- Reference sequences (33%)
- Benign variants (33%)
- Pathogenic variants (33%)

And predict:
- 9 Phase 1 tasks
- Variant effects (Phase 2B)
